Literature DB >> 24487185

The immune contexture of primary and metastatic human tumours.

Nicolas A Giraldo1, Etienne Becht1, Romain Remark1, Diane Damotte2, Catherine Sautès-Fridman1, Wolf H Fridman3.   

Abstract

A tumour grows in a complex microenvironment composed of stromal cells, lymphoid and myeloid cells, vascular and lymphatic vessels, and the resultant cytokine and chemokine milieu. In most primary tumours, a strong Th1/cytotoxic T cells infiltration correlates with a longer survival. This beneficial effect can be hampered by the presence of M2 polarized macrophages and high VEGF production. Recent studies revealed that the pattern of the tumour microenvironment remains a major prognostic factor even in the metastatic lesions, while been reproducible between the primary and metastatic tumour. Nevertheless the prognostic impact of the Th1/cytotoxic T cell infiltrate could be different according to the origin of the primary tumour. This model highlights a novel tumour cell-dependent immune contexture that predicts patient's clinical outcome and has implications in the use of immunotherapies.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24487185     DOI: 10.1016/j.coi.2014.01.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  43 in total

Review 1.  The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.

Authors:  Romain Remark; Christian Becker; Jorge E Gomez; Diane Damotte; Marie-Caroline Dieu-Nosjean; Catherine Sautès-Fridman; Wolf-Herman Fridman; Charles A Powell; Nasser K Altorki; Miriam Merad; Sacha Gnjatic
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

2.  Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients.

Authors:  Audrey Hennequin; Valentin Derangère; Romain Boidot; Lionel Apetoh; Julie Vincent; David Orry; Jean Fraisse; Sylvain Causeret; François Martin; Laurent Arnould; Françoise Beltjens; François Ghiringhelli; Sylvain Ladoire
Journal:  Oncoimmunology       Date:  2015-06-03       Impact factor: 8.110

Review 3.  Metastatic niche functions and therapeutic opportunities.

Authors:  Toni Celià-Terrassa; Yibin Kang
Journal:  Nat Cell Biol       Date:  2018-07-26       Impact factor: 28.824

Review 4.  T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.

Authors:  David Schrama; Cathrin Ritter; Jürgen C Becker
Journal:  Semin Immunopathol       Date:  2017-01-10       Impact factor: 9.623

5.  The significance of cytokine-producing B cells in breast tumor-draining lymph nodes.

Authors:  Fereshteh Mehdipour; Mahboobeh Razmkhah; Zahra Faghih; Mandana Bagheri; Abdol-Rasoul Talei; Abbas Ghaderi
Journal:  Cell Oncol (Dordr)       Date:  2019-03-08       Impact factor: 6.730

6.  Immune signature of tumor infiltrating immune cells in renal cancer.

Authors:  Katharina Geissler; Paolo Fornara; Christine Lautenschläger; Hans-Jürgen Holzhausen; Barbara Seliger; Dagmar Riemann
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

Review 7.  Systems immune monitoring in cancer therapy.

Authors:  Allison R Greenplate; Douglas B Johnson; P Brent Ferrell; Jonathan M Irish
Journal:  Eur J Cancer       Date:  2016-05-04       Impact factor: 9.162

8.  T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors.

Authors:  Jiemiao Hu; Chuang Sun; Chantale Bernatchez; Xueqing Xia; Patrick Hwu; Gianpietro Dotti; Shulin Li
Journal:  Clin Cancer Res       Date:  2018-02-01       Impact factor: 12.531

9.  Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.

Authors:  Marieta Toma; Rebekka Wehner; Anja Kloß; Linda Hübner; Georgia Fodelianaki; Kati Erdmann; Susanne Füssel; Stefan Zastrow; Matthias Meinhardt; Barbara Seliger; Dorothee Brech; Elfriede Noessner; Torsten Tonn; Knut Schäkel; Martin Bornhäuser; Michael P Bachmann; Manfred P Wirth; Gustavo Baretton; Marc Schmitz
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

Review 10.  Combination cancer immunotherapies tailored to the tumour microenvironment.

Authors:  Mark J Smyth; Shin Foong Ngiow; Antoni Ribas; Michele W L Teng
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.